David Summa

David Summa

Presidente en
IONpath, Inc.
.
Health Technology
Commercial Services
Process Industries

Perfil

David W.
Summa
is currently the Executive Chairman at IONpath, Inc. since 2023 and an Advisor at Peaxy, Inc. since 2016.
Previously, he served as the President & Chief Executive Officer at Mendel Biotechnology, Inc. from 1999 to 2002.
He also held positions as a Director at Monsanto Co., Director at Sequoia Pharmaceuticals, Inc., Director at Acumen Pharmaceuticals, Inc., Director at Agrivida, Inc., Director at Alliance of Chief Executives LLC from 2020 to 2021, and Chief Business Officer at Mascoma Corp.
He was a Vice President at Halio, Inc. in 2012.
Prior to that, he worked as a Partner at McKinsey & Co., Inc. from 1989 to 1996.
Additionally, he served as the Executive Vice President at Kiverdi, Inc. in 2015 and as an Operating Partner at Genoa Ventures LLC from 2021 to 2023.
Mr. Summa obtained his undergraduate and graduate degrees from the Massachusetts Institute of Technology in 1981 and 1985, respectively.

Cargos activos de David Summa

EmpresasCargoInicio
Consultor / Asesor 01/02/2016
Presidente 06/12/2023

Antiguos cargos conocidos de David Summa.

EmpresasCargoFin
Inversor de Capital Privado 01/11/2023
Director/Miembro de la Junta 02/12/2021
Inversor de Capital Privado 02/11/2015
Inversor de Capital Privado 02/10/2012
ACUMEN PHARMACEUTICALS, INC. Director/Miembro de la Junta 02/01/2008
Ver el detalle de la experiencia de David Summa.

Formación de David Summa.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

87

Relaciones de 1er grado

14

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas14

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Process Industries

Commercial Services

Commercial Services

Finance

Commercial Services

Health Technology

Process Industries

Finance

Technology Services